February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
Nvidia Stock: Evaluating Competitive Risks Amid Growth Prospects
Apple: Valuation Concerns Persist Amid Fundamental Strength
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
EyePoint Pharmaceuticals (EYPT) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: February 14, 2025 (15:04)
Sector: HealthcareThe share price of EyePoint Pharmaceuticals, Inc. (EYPT) now
Are you interested in EyePoint Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the EyePoint Pharmaceuticals stock price in 2025, 2026, 2027. How much will one EyePoint Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in EyePoint Pharmaceuticals stock? When should I record a loss on EyePoint Pharmaceuticals stock? What are analysts' forecasts for EyePoint Pharmaceuticals stock? What is the future of EyePoint Pharmaceuticals stock? We forecast EyePoint Pharmaceuticals stock performance using neural networks based on historical data on EyePoint Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
EyePoint Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for EyePoint Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of EyePoint Pharmaceuticals stock
The chart below shows the historical price of EyePoint Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the EyePoint Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development and commercializing of ophthalmic products. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
EyePoint Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Feb 16 | 6.50 | 6.30 | 6.66 | 5.67 |
| Feb 17 | 6.66 | 6.46 | 6.90 | 6.70 |
| Feb 18 | 6.55 | 6.42 | 6.68 | 4.03 |
| Feb 19 | 6.65 | 6.38 | 6.91 | 8.18 |
| Feb 20 | 6.77 | 6.63 | 6.87 | 3.62 |
| Feb 21 | 7.00 | 6.91 | 7.21 | 4.31 |
| Feb 22 | 7.05 | 6.93 | 7.23 | 4.27 |
| Feb 23 | 6.98 | 6.74 | 7.08 | 5.02 |
| Feb 24 | 7.21 | 6.98 | 7.34 | 5.06 |
| Feb 25 | 7.07 | 6.89 | 7.27 | 5.49 |
| Feb 26 | 6.97 | 6.70 | 7.06 | 5.41 |
| Feb 27 | 7.20 | 7.10 | 7.28 | 2.43 |
| Feb 28 | 7.22 | 7.12 | 7.39 | 3.85 |
| Mar 01 | 7.56 | 7.41 | 7.72 | 4.19 |
| Mar 02 | 7.90 | 7.78 | 8.09 | 3.96 |
| Mar 03 | 7.81 | 7.53 | 8.04 | 6.69 |
| Mar 04 | 7.85 | 7.62 | 8.01 | 5.10 |
| Mar 05 | 7.74 | 7.61 | 8.00 | 5.19 |
| Mar 06 | 7.75 | 7.55 | 7.86 | 4.11 |
| Mar 07 | 7.84 | 7.69 | 8.09 | 5.20 |
| Mar 08 | 7.85 | 7.76 | 8.04 | 3.69 |
| Mar 09 | 7.47 | 7.39 | 7.74 | 4.80 |
| Mar 10 | 7.33 | 7.11 | 7.57 | 6.44 |
| Mar 11 | 7.32 | 7.24 | 7.45 | 2.93 |
| Mar 12 | 7.25 | 7.09 | 7.54 | 6.29 |
| Mar 13 | 7.50 | 7.38 | 7.62 | 3.20 |
| Mar 14 | 7.16 | 6.92 | 7.30 | 5.37 |
| Mar 15 | 6.89 | 6.73 | 6.97 | 3.59 |
| Mar 16 | 6.89 | 6.79 | 7.14 | 5.13 |
| Mar 17 | 6.65 | 6.53 | 6.91 | 5.86 |
EyePoint Pharmaceuticals Daily Price Targets
EyePoint Pharmaceuticals Stock Forecast 02-16-2025.
Forecast target price for 02-16-2025: $6.50.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 5.368%.
Pessimistic target level: 6.30
Optimistic target level: 6.66
EyePoint Pharmaceuticals Stock Forecast 02-17-2025.
Forecast target price for 02-17-2025: $6.66.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 6.280%.
Pessimistic target level: 6.46
Optimistic target level: 6.90
EyePoint Pharmaceuticals Stock Forecast 02-18-2025.
Forecast target price for 02-18-2025: $6.55.
Negative dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 3.876%.
Pessimistic target level: 6.42
Optimistic target level: 6.68
EyePoint Pharmaceuticals Stock Forecast 02-19-2025.
Forecast target price for 02-19-2025: $6.65.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 7.559%.
Pessimistic target level: 6.38
Optimistic target level: 6.91
EyePoint Pharmaceuticals Stock Forecast 02-20-2025.
Forecast target price for 02-20-2025: $6.77.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 3.496%.
Pessimistic target level: 6.63
Optimistic target level: 6.87
EyePoint Pharmaceuticals Stock Forecast 02-21-2025.
Forecast target price for 02-21-2025: $7.00.
Positive dynamics for EyePoint Pharmaceuticals shares will prevail with possible volatility of 4.130%.
Pessimistic target level: 6.91
Optimistic target level: 7.21
EYPT (EYPT) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Mar. | 7.66 | 6.52 | 8.16 | 20.13 |
| Apr. | 8.86 | 7.92 | 9.50 | 16.66 |
| May. | 8.51 | 7.78 | 9.64 | 19.29 |
| Jun. | 8.65 | 7.59 | 9.36 | 18.97 |
| Jul. | 7.59 | 6.86 | 8.57 | 19.85 |
| Aug. | 8.65 | 7.80 | 8.98 | 13.18 |
| Sep. | 8.19 | 7.07 | 9.36 | 24.45 |
| Oct. | 7.96 | 6.82 | 8.31 | 17.84 |
| Nov. | 8.71 | 8.04 | 9.26 | 13.23 |
| Dec. | 10.20 | 9.06 | 10.94 | 17.19 |
EyePoint Pharmaceuticals forecast for this year
EyePoint Pharmaceuticals Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $7.65501. Pessimistic: $6.52. Optimistic: $8.16
EyePoint Pharmaceuticals Stock Prediction for Apr 2025
An uptrend is forecast for this month with an optimal target price of $8.8622. Pessimistic: $7.92. Optimistic: $9.50
EyePoint Pharmaceuticals Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $8.5086. Pessimistic: $7.78. Optimistic: $9.64
EyePoint Pharmaceuticals Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $8.6541. Pessimistic: $7.59. Optimistic: $9.36
EyePoint Pharmaceuticals Stock Prediction for Jul 2025
An downtrend is forecast for this month with an optimal target price of $7.58532. Pessimistic: $6.86. Optimistic: $8.57
EyePoint Pharmaceuticals Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $8.65181. Pessimistic: $7.80. Optimistic: $8.98
EyePoint Pharmaceuticals Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $8.19153. Pessimistic: $7.07. Optimistic: $9.36
EyePoint Pharmaceuticals Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $7.95808. Pessimistic: $6.82. Optimistic: $8.31
EyePoint Pharmaceuticals Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $8.71409. Pessimistic: $8.04. Optimistic: $9.26
EyePoint Pharmaceuticals Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $10.2042. Pessimistic: $9.06. Optimistic: $10.94
EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 9.95 | 8.84 | 10.95 | 19.33 |
| Feb | 9.76 | 8.65 | 11.23 | 22.96 |
| Mar | 10.91 | 9.57 | 11.37 | 15.87 |
| Apr | 12.03 | 10.78 | 13.82 | 22.01 |
| May | 13.20 | 11.79 | 13.98 | 15.61 |
| Jun | 15.38 | 13.13 | 17.48 | 24.90 |
| Jul | 15.61 | 14.16 | 17.57 | 19.42 |
| Aug | 16.15 | 14.74 | 17.04 | 13.51 |
| Sep | 15.04 | 13.81 | 16.59 | 16.71 |
| Oct | 14.62 | 12.39 | 16.75 | 26.02 |
| Nov | 13.95 | 12.65 | 14.80 | 14.51 |
| Dec | 14.40 | 13.82 | 16.48 | 16.10 |
EyePoint Pharmaceuticals (EYPT) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 13.33 | 11.51 | 13.86 | 16.99 |
| Feb | 15.08 | 13.99 | 16.60 | 15.71 |
| Mar | 14.82 | 13.05 | 16.51 | 20.98 |
| Apr | 16.31 | 14.64 | 18.64 | 21.45 |
| May | 16.87 | 15.14 | 18.09 | 16.30 |
| Jun | 18.12 | 16.30 | 19.43 | 16.13 |
| Jul | 18.88 | 17.55 | 20.75 | 15.39 |
| Aug | 18.63 | 15.80 | 21.35 | 26.02 |
| Sep | 16.68 | 15.22 | 17.44 | 12.72 |
| Oct | 16.37 | 14.90 | 18.82 | 20.82 |
| Nov | 18.01 | 16.75 | 19.69 | 14.95 |
| Dec | 19.21 | 17.17 | 20.20 | 15.00 |
EyePoint Pharmaceuticals information and performance
480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US
Market capitalization of the EyePoint Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of EYPT shares in the company outstanding by the market price of one share.
EBITDA of EyePoint Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
EyePoint Pharmaceuticals (EYPT) stock dividend
EyePoint Pharmaceuticals last paid dividends on 01/01/1970. The next scheduled payment will be on 12/09/2020. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
FAQ (Frequently Asked Questions about EyePoint Pharmaceuticals Stock)
Should I Buy EyePoint Pharmaceuticals Shares in 2025 year?
Does EyePoint Pharmaceuticals pay dividends?
Which economic sector do EyePoint Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as EyePoint Pharmaceuticals's shares?
